Timely Pharmaceutical Industry Study Delivers Insights into Improving the Impact of Field Based Medical Teams in Major Global Markets
CHAPEL HILL, N.C., Dec. 7, 2018 /PRNewswire/ -- One of the clear trends in the pharmaceutical industry is the rising importance of field medical teams.
In 2019, pharmaceutical companies will rely even more heavily on Medical Science Liaisons (MSLs) and other Field-Based Medical Specialists (FBMS) to build and strengthen vital relationships with physicians, key opinion leaders, and even payers. However, pharma organizations face numerous challenges in effectively structuring and aligning MSLs and FBMS across global organizations.
To help field medical team leaders identify effective globalization practices and prepare for the year ahead, research and consulting leader Best Practices, LLC conducted a primary research project that fills knowledge gaps around key MSL/field-based medical team operational areas.
The study - Optimizing the Size and Improving the Impact of Field-Based Medical Teams in Major Global Markets - investigates how leading companies successfully manage globalization challenges. Topics addressed in the study include staffing levels, resource allocations, productivity measures, efficiency (time spent on key external and internal activities), frequency of thought leader interactions by tier, effective communication channels, and tactics and tools for leveraging field insights across the organization.
Issues explored in this report include:
- Optimization of field-based medical team staffing levels
- Regional differences when building field-based medical teams
- Number of thought leaders that are supported by MSLs
- How field teams are staffed depending on stage of product lifecycle
- Budget allocations and revenue supported per MSL
- Duration and frequency of MSL and HOL interactions
- The degree of proactive vs. reactive interactions
- Time spent on internal and external activities
In the study, respondents reported that face-to-face meetings constitute 65 percent of all MSL interactions with thought leaders, with 100% of companies across all regions deeming them a "highly effective" engagement channel.
Data in this study are based on 69 survey responses from 55 field medical experts; responses were pooled into segments to provide critical insights into global responses (n=38) and target regions of North America, EU and JAPAC. In addition, six executive interviews were conducted with selected respondents.
To learn more about this report, download a complimentary report excerpt at https://www.best-in-class.com/rr1522.htm.
For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.